Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Aveo's new drug looks better and their next drug doesn't look like it has the blockbuster potential of their kidney cancer drug.
Sold mine in real life, too.

Onyx has scored a major victory against Bayer in getting rights to regorafenib. Carfilzomib looks great.

Strong pipeline

Earnings Estimates Revised Downward

developement of sucessful drug

Based on hopes of further approvals in 2010.

porte

my be a bore in the short term, but long term it will be a winner

Well undervalue mid-sized biotech with a buyout potential over $50 and possible positive clinical results in 2 years.

Mmm...pharmaceuticals...

I think people will use this drug for alternative cancer treatments before approved by the FDA. It's already greenlighted in many countries abroad.

Good market but stale growth right now.

Target 40.50

Onyx will get bought out within two years.

bullish

ONXX reports strong revenue growth on Nexavar sales. 2008 Nexava Net sales of $678M, 82% annual growth, makes 2008 the first full year profitable although more R&D cost. New indications are progressing well. A long position for a long time.

The Obama Plan for Healthcare:

1) Barack Obama will make health insurance affordable and accessible to all:

The Obama-Biden plan provides affordable, accessible health care for all Americans, builds on the existing healthcare system, and uses existing providers, doctors and plans to implement the plan.

2) Obama will lower health care costs:

The Obama plan will lower health care costs by $2,500 for a typical family by investing in health information technology, prevention and care coordination.

3) Promote public health:

Obama and Biden will require coverage of preventive services, including cancer screenings, and will increase state and local preparedness for terrorist attacks and natural disasters.

"http://www.barackobama.com/issues/healthcare/"

Possible buyout by Bayer

Onxx baby!